Sector: University & Research Institutions

Latest content

Time for CRISPR Cas9 patent enforcement approaching, says IP licensing chief on CVC side

ERS Genomics seeking to educate market on need to take a licence, says Michael Arciero, but litigation may soon be necessary

06 May 2024

Using trade secrets strategy to steer a driverless software company to success 

Oxa’s Head of Licensing and IP Management Alex Tame explains his philosophy on efficient IP management in the nascent but competitive autonomous vehicle market

12 April 2024

BioNTech facing fresh mRNA spat in vaccine patent royalties dispute

The covid-19 IP war’s most prolific defendant finds itself on the brink of litigation in another fight

27 March 2024

Broad Institute gets huge CRISPR boost from Board of Appeal decision

Many applicants could benefit from the EPO’s latest appellate decision on priority entitlement

26 March 2024

Trade secrets managers should take note: a UK law criminalising theft is now in play

The National Security Act 2023 gives an extra layer of protection to trade secrets against foreign espionage and moves prosecution to government control

27 February 2024

Fractus’ first IoT deal will hopefully drive further agreements, says SME’s licensing VP

IAM speaks exclusively to Jordi Ilario about the Catalan licensing business’s Vivint deal and ongoing projects

21 February 2024

NanoString bankrupted by patent litigation, with major ramifications for ongoing 10x dispute

Everything you need to know about how the Chapter 11 process impacts the companies’ high-profile spat

08 February 2024

‘Fathers of MP3’ call for EU to abandon proposed SEP regulation

IAM talks exclusively to two of the top European scientists speaking out against the “harmful” new licensing framework

29 January 2024

Cloudera’s $240 million verdict crowned largest in US in Q4 2023

The data storage firm’s loss was the fourth-highest award in the last 12 months, with Google’s $338.8 million defeat topping the heap

08 January 2024

Editas licenses CRISPR patents to Vertex in $100 million-plus deal

The speedy agreement prevents litigation between the two parties, but other Cas9 disputes may be on the cards

14 December 2023

Unlock unlimited access to all IAM content